Li‐Yan Xu

13.1k total citations · 1 hit paper
367 papers, 7.5k citations indexed

About

Li‐Yan Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Li‐Yan Xu has authored 367 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Molecular Biology, 71 papers in Pulmonary and Respiratory Medicine and 67 papers in Cancer Research. Recurrent topics in Li‐Yan Xu's work include Esophageal Cancer Research and Treatment (55 papers), RNA modifications and cancer (34 papers) and Epigenetics and DNA Methylation (29 papers). Li‐Yan Xu is often cited by papers focused on Esophageal Cancer Research and Treatment (55 papers), RNA modifications and cancer (34 papers) and Epigenetics and DNA Methylation (29 papers). Li‐Yan Xu collaborates with scholars based in China, United States and Canada. Li‐Yan Xu's co-authors include En‐Min Li, Xiu‐E Xu, Lian‐Di Liao, Jian‐Yi Wu, Jian‐Jun Xie, Zhong‐Ying Shen, Zhi‐Yong Wu, Jin‐Hui Shen, Bingli Wu and Zepeng Du and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Li‐Yan Xu

353 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guide to Metabolomics Analysis: A Bioinformatics Workflow

2022 164 citations En‐Min Li, Li‐Yan Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Yan Xu China	44	4.5k	2.0k	1.4k	1.0k	984	367	7.5k
En‐Min Li China	42	4.0k 0.9×	1.7k 0.8×	1.1k 0.8×	835 0.8×	790 0.8×	293	6.2k
Tao Wang China	42	4.0k 0.9×	2.3k 1.1×	1.0k 0.7×	848 0.8×	791 0.8×	284	6.3k
Rosamonde E. Banks United Kingdom	51	5.1k 1.1×	1.6k 0.8×	1.5k 1.1×	1.4k 1.3×	1.1k 1.1×	162	8.8k
Giuseppe Viglietto Italy	48	5.4k 1.2×	1.6k 0.8×	2.3k 1.6×	803 0.8×	841 0.9×	150	8.2k
George E. Sandusky United States	46	5.3k 1.2×	1.3k 0.6×	1.2k 0.9×	964 0.9×	1.6k 1.6×	201	9.6k
Pankaj K. Singh United States	44	3.7k 0.8×	1.7k 0.8×	1.8k 1.3×	676 0.6×	524 0.5×	123	6.1k
Ambra Pozzi United States	53	4.0k 0.9×	1.4k 0.7×	1.3k 0.9×	665 0.6×	642 0.7×	173	8.5k
Jayoung Kim United States	43	3.4k 0.8×	1.8k 0.9×	841 0.6×	898 0.9×	923 0.9×	175	6.0k
Bhaskar Kallakury United States	46	3.3k 0.7×	1.6k 0.8×	2.2k 1.6×	1.8k 1.7×	1.0k 1.0×	207	7.5k
Dan Li China	45	5.6k 1.2×	3.6k 1.7×	1.5k 1.1×	837 0.8×	454 0.5×	390	8.7k

Countries citing papers authored by Li‐Yan Xu

Since Specialization

Citations

This map shows the geographic impact of Li‐Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Yan Xu more than expected).

Fields of papers citing papers by Li‐Yan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Yan Xu. The network helps show where Li‐Yan Xu may publish in the future.

Co-authorship network of co-authors of Li‐Yan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Yan Xu. A scholar is included among the top collaborators of Li‐Yan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Yan Xu. Li‐Yan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Yunlan, et al.. (2024). TGF-β1-mediated upregulation of LMCD1 drives corneal myofibroblast differentiation and corneal fibrosis. Experimental Eye Research. 249. 110130–110130.

Zou, Ying, Xiaolong Lu, Jin Cai, et al.. (2024). Synthesis of fluorescent polymers from hydrostyryl pyridinium derivatives and their multichromatic fluorescence behaviors. European Polymer Journal. 208. 112850–112850. 1 indexed citations

Lin, Wan‐Wan, Junwu Su, Qingfeng Huang, et al.. (2024). NIR-715 photodynamic therapy induces immunogenic cancer cell death by enhancing the endoplasmic reticulum stress response. Cell Death and Disease. 15(12). 890–890. 7 indexed citations

Xu, Li‐Yan, et al.. (2024). Conformation Changes Associated with the Formation and Activation of Lysine Tyrosylquinone of LOXL2 Studied by Metadynamics Simulation. Advanced Theory and Simulations. 7(4). 1 indexed citations

Xu, Li‐Yan, et al.. (2023). Mitochondrial DNA heteroplasmy analysis in keratoconus patients from China. Frontiers in Genetics. 14. 1251951–1251951.

Li, Kang, Huifang Zhang, Jianzhong He, et al.. (2023). Control of SOX2 protein stability and tumorigenic activity by E3 ligase CHIP in esophageal cancer cells. Oncogene. 42(30). 2315–2328. 3 indexed citations

Li, Xiang, Liyan Li, Xiaodong Wu, et al.. (2022). Anti‐tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation. FEBS Journal. 289(21). 6782–6798. 3 indexed citations

Yang, Qing, Yubin Su, Yin Ji, et al.. (2021). MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death and Disease. 12(6). 511–511. 123 indexed citations

Xu, Li‐Yan, Jian Zhang, Shanshan Shen, et al.. (2020). Association Between Body Composition and Frailty in Elder Inpatients. SHILAP Revista de lepidopterología. 3 indexed citations

10.

Yang, Dongzhi, Ya Li, Yan Xu, et al.. (2020). A c.544_618del75bp mutation in the splicing factor gene PRPF31 is involved in non‐syndromic retinitis pigmentosa by reducing the level of mRNA expression. Ophthalmic and Physiological Optics. 40(3). 289–299. 3 indexed citations

11.

Jiao, Jiwei, Haifeng Zhang, Xiu‐E Xu, et al.. (2019). LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion. Cancer Research. 79(19). 4951–4964. 53 indexed citations

12.

Zhao, Jianmei, Xuecang Li, Jincheng Guo, et al.. (2019). ReCirc: prediction of circRNA expression and function through probe reannotation of non-circRNA microarrays. Molecular Omics. 15(2). 150–163. 4 indexed citations

13.

Xu, Li‐Yan, et al.. (2019). Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Cheng, Yinwei, Lian‐Di Liao, Qian Yang, et al.. (2018). The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest. Cell Biochemistry and Function. 36(8). 398–407. 18 indexed citations

15.

Guo, Jincheng, Chunquan Li, Qiuyu Wang, et al.. (2016). Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature. Molecular BioSystems. 12(11). 3467–3477. 31 indexed citations

16.

Zhang, Hai-Feng, Ye Chen, Chengsheng Wu, et al.. (2015). The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 22(3). 691–703. 45 indexed citations

17.

Peng, Yu‐Hui, Yi‐Wei Xu, Tian‐Tian Zhai, et al.. (2015). Autoantibody Signatures Combined with Epstein–Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma. Cancer Prevention Research. 8(8). 729–736. 21 indexed citations

18.

Bi, Xiuli, Xin Song, Nicole M. Pohl, et al.. (2013). A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular Carcinogenesis. 52(S1). 80–86. 14 indexed citations

19.

Hou, Jian, Lian‐Di Liao, Yang‐Min Xie, et al.. (2013). DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma. Cancer Prevention Research. 6(8). 791–800. 22 indexed citations

20.

Cui, Lei, Li‐Yan Xu, Qian Tao, et al.. (2008). NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 14(23). 7674–7681. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact